Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))

Cheng Zhang; Mengnan Shi; Woonghee Kim; Muhammad Arif; Martina Klevstig; Xiangyu Li; Hong Yang; Cemil Bayram; Ismail Bolat; Özlem Özdemir Tozlu; Ahmet Hacımuftuoglu; Serkan Yıldırım; Jihad Sebhaoui; Shazia Iqbal; Yongjun Wei; Xiaojing Shi; Jens Nielsen; Hasan Turkez; Mathias Uhlen; Jan Boren; Adil Mardinoglu

doi:10.1016/j.ebiom.2024.105224

Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))

Cheng Zhang, Mengnan Shi, Woonghee Kim, Muhammad Arif, Martina Klevstig, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Özlem Özdemir Tozlu, Ahmet Hacımuftuoglu, Serkan Yıldırım, Jihad Sebhaoui, Shazia Iqbal, Yongjun Wei, Xiaojing Shi, Jens Nielsen, Hasan Turkez, Mathias Uhlen, Jan Boren^*Adil Mardinoglu^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

1 Downloads (Pure)

Abstract

The authors have been alerted that the figure legend of Fig. 5 [Figure presented] is incompletely presented in the PDF version, although it appears in full in the online version. Upon reviewing our original documents, the authors also discovered inaccuracies in Figs. 5B and 6 [Figure presented]B. The mistakes were made inadvertently during the preparation of the figures. The same image created by the research team was uploaded twice in Fig. 5B (top and middle panels), and a separate panel from Fig. 5C (middle panel from BX-912 stomach) was repeated unintentionally in Fig. 6B under the middle HSD + BX-912 stomach panel. The authors would like to apologize to the journal and the readers for these unintentional errors that were made when the figures were assembled. Fig. 5B and 6B and their legends have been corrected. The other manuscript contents will remain unchanged. The corrections do not affect the results or conclusions of the study. The authors apologize for the inconvenience caused by these unintentional errors.

Original language	English
Article number	105224
Journal	EBioMedicine
Volume	105
Early online date	28 Jun 2024
DOIs	https://doi.org/10.1016/j.ebiom.2024.105224
Publication status	Published - Jul 2024

Access to Document

10.1016/j.ebiom.2024.105224Licence: CC BY-NC-ND

Corrigendum to Discovery of_ZHANG_Publishedonline28June2024_GOLD_VoR (CC BY-NC-ND)Final published version, 1.85 MBLicence: CC BY-NC-ND

Fingerprint

Dive into the research topics of 'Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))'. Together they form a unique fingerprint.

Cite this

Zhang, C., Shi, M., Kim, W., Arif, M., Klevstig, M., Li, X., Yang, H., Bayram, C., Bolat, I., Tozlu, Ö. Ö., Hacımuftuoglu, A., Yıldırım, S., Sebhaoui, J., Iqbal, S., Wei, Y., Shi, X., Nielsen, J., Turkez, H., Uhlen, M., ... Mardinoglu, A. (2024). Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214)). EBioMedicine, 105, Article 105224. https://doi.org/10.1016/j.ebiom.2024.105224

@article{7934528b62e9483aba8852424a8e94cc,

title = "Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))",

abstract = "The authors have been alerted that the figure legend of Fig. 5 [Figure presented] is incompletely presented in the PDF version, although it appears in full in the online version. Upon reviewing our original documents, the authors also discovered inaccuracies in Figs. 5B and 6 [Figure presented]B. The mistakes were made inadvertently during the preparation of the figures. The same image created by the research team was uploaded twice in Fig. 5B (top and middle panels), and a separate panel from Fig. 5C (middle panel from BX-912 stomach) was repeated unintentionally in Fig. 6B under the middle HSD + BX-912 stomach panel. The authors would like to apologize to the journal and the readers for these unintentional errors that were made when the figures were assembled. Fig. 5B and 6B and their legends have been corrected. The other manuscript contents will remain unchanged. The corrections do not affect the results or conclusions of the study. The authors apologize for the inconvenience caused by these unintentional errors.",

author = "Cheng Zhang and Mengnan Shi and Woonghee Kim and Muhammad Arif and Martina Klevstig and Xiangyu Li and Hong Yang and Cemil Bayram and Ismail Bolat and Tozlu, {{\"O}zlem {\"O}zdemir} and Ahmet Hacımuftuoglu and Serkan Yıldırım and Jihad Sebhaoui and Shazia Iqbal and Yongjun Wei and Xiaojing Shi and Jens Nielsen and Hasan Turkez and Mathias Uhlen and Jan Boren and Adil Mardinoglu",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s)",

year = "2024",

month = jul,

doi = "10.1016/j.ebiom.2024.105224",

language = "English",

volume = "105",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

Zhang, C, Shi, M, Kim, W, Arif, M, Klevstig, M, Li, X, Yang, H, Bayram, C, Bolat, I, Tozlu, ÖÖ, Hacımuftuoglu, A, Yıldırım, S, Sebhaoui, J, Iqbal, S, Wei, Y, Shi, X, Nielsen, J, Turkez, H, Uhlen, M, Boren, J & Mardinoglu, A 2024, 'Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))', EBioMedicine, vol. 105, 105224. https://doi.org/10.1016/j.ebiom.2024.105224

Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214)). / Zhang, Cheng; Shi, Mengnan; Kim, Woonghee et al.
In: EBioMedicine, Vol. 105, 105224, 07.2024.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))

AU - Zhang, Cheng

AU - Shi, Mengnan

AU - Kim, Woonghee

AU - Arif, Muhammad

AU - Klevstig, Martina

AU - Li, Xiangyu

AU - Yang, Hong

AU - Bayram, Cemil

AU - Bolat, Ismail

AU - Tozlu, Özlem Özdemir

AU - Hacımuftuoglu, Ahmet

AU - Yıldırım, Serkan

AU - Sebhaoui, Jihad

AU - Iqbal, Shazia

AU - Wei, Yongjun

AU - Shi, Xiaojing

AU - Nielsen, Jens

AU - Turkez, Hasan

AU - Uhlen, Mathias

AU - Boren, Jan

AU - Mardinoglu, Adil

PY - 2024/7

Y1 - 2024/7

N2 - The authors have been alerted that the figure legend of Fig. 5 [Figure presented] is incompletely presented in the PDF version, although it appears in full in the online version. Upon reviewing our original documents, the authors also discovered inaccuracies in Figs. 5B and 6 [Figure presented]B. The mistakes were made inadvertently during the preparation of the figures. The same image created by the research team was uploaded twice in Fig. 5B (top and middle panels), and a separate panel from Fig. 5C (middle panel from BX-912 stomach) was repeated unintentionally in Fig. 6B under the middle HSD + BX-912 stomach panel. The authors would like to apologize to the journal and the readers for these unintentional errors that were made when the figures were assembled. Fig. 5B and 6B and their legends have been corrected. The other manuscript contents will remain unchanged. The corrections do not affect the results or conclusions of the study. The authors apologize for the inconvenience caused by these unintentional errors.

AB - The authors have been alerted that the figure legend of Fig. 5 [Figure presented] is incompletely presented in the PDF version, although it appears in full in the online version. Upon reviewing our original documents, the authors also discovered inaccuracies in Figs. 5B and 6 [Figure presented]B. The mistakes were made inadvertently during the preparation of the figures. The same image created by the research team was uploaded twice in Fig. 5B (top and middle panels), and a separate panel from Fig. 5C (middle panel from BX-912 stomach) was repeated unintentionally in Fig. 6B under the middle HSD + BX-912 stomach panel. The authors would like to apologize to the journal and the readers for these unintentional errors that were made when the figures were assembled. Fig. 5B and 6B and their legends have been corrected. The other manuscript contents will remain unchanged. The corrections do not affect the results or conclusions of the study. The authors apologize for the inconvenience caused by these unintentional errors.

UR - http://www.scopus.com/inward/record.url?scp=85197341541&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2024.105224

DO - 10.1016/j.ebiom.2024.105224

M3 - Comment/debate

C2 - 38943726

AN - SCOPUS:85197341541

SN - 2352-3964

VL - 105

JO - EBioMedicine

JF - EBioMedicine

M1 - 105224

ER -

Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214] (eBioMedicine (2022) 83, (S2352396422003966), (10.1016/j.ebiom.2022.104214))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this